← Leaderboards
Pavithra Viswanath
University Of California, San Francisco
$6,465,079
Attributed
$8,050,536
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2020–25$5M$3.8M$2.5M$1.3M$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,050,536 · 8
By mechanism
R01$5,848,240 · 4
R21$1,234,446 · 3
P01$967,850 · 1
Top collaborators
- Sabrina Miriam Ronen5 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Sabrina Miriam Ronen$18,398,578
- Sabine Mueller$1,826,791
- Zhen Jane Wang$4,501,373
- David M Wilson$11,449,852
- Michael Hyunjean Lee$606,190
Others in their field
Other Emerging Leaders on “Tumor”
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Lynn Briscoe · Leidos Biomedical Research, Inc.$120,794,323
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$105,180,681
- Leonard Freedmand · Leidos Biomedical Research, Inc.$78,762,245
- Connie Suders · Leidos Biomedical Research, Inc.$67,882,919
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
Research focus
TumorInnovationMetabolic ImagingImageMetabolismMetabolicIn VivoQuality Of LifeEnzymesBrain NeoplasmsProliferatingGlucoseGlucose MetabolismCellsImaging ModalityMalignant NeoplasmsResponseBiological MarkersMagnetic Resonance SpectroscopyMutationTreatment ResponseImaging BiomarkerClinical TranslationMolecular
Grant awards (17)
Probing citrate metabolism in tumor and immune cells in diffuse midline gliomas$686,979
R01 · FY2025 · CA · contact PI
Combination metabolic therapy for diffuse midline glioma$664,137
R01 · FY2025 · CA · contact PI
Leveraging reactive metabolite generation in brain tumors$655,306
R01 · FY2025 · CA · contact PI
Project 3: Preclinical metabolic imaging of molecular alterations of meningiomas$483,925
P01 · FY2025 · CA · contact PI
Spatial Mapping of Phospholipid Biosynthesis in Brain Tumors$226,504
R21 · FY2025 · CA · contact PI
Synthetic combination therapy for diffuse midline gliomas$188,753
R21 · FY2025 · CA · contact PI
Combination metabolic therapy for diffuse midline glioma$670,904
R01 · FY2024 · CA · contact PI
IMAGING TELOMERE MAINTENANCE MECHANISMS IN GLIOMAS$560,881
R01 · FY2024 · CA · contact PI
Project 3: Preclinical metabolic imaging of molecular alterations of meningiomas$483,925
P01 · FY2024 · CA · contact PI
Synthetic combination therapy for diffuse midline gliomas$226,504
R21 · FY2024 · CA · contact PI
Targeting metabolic vulnerabilities induced by the 1p19q codeletion in oligodendrogliomas$215,179
R21 · FY2024 · CA · contact PI
Spatial Mapping of Phospholipid Biosynthesis in Brain Tumors$188,753
R21 · FY2024 · CA · contact PI
IMAGING TELOMERE MAINTENANCE MECHANISMS IN GLIOMAS$655,952
R01 · FY2023 · CA · contact PI
Targeting metabolic vulnerabilities induced by the 1p19q codeletion in oligodendrogliomas$188,753
R21 · FY2023 · CA · contact PI
IMAGING TELOMERE MAINTENANCE MECHANISMS IN GLIOMAS$644,129
R01 · FY2022 · CA · contact PI
IMAGING TELOMERE MAINTENANCE MECHANISMS IN GLIOMAS$648,075
R01 · FY2021 · CA · contact PI
IMAGING TELOMERE MAINTENANCE MECHANISMS IN GLIOMAS$661,877
R01 · FY2020 · CA · contact PI